PL1606233T3 - Estry fosfolipidowe klofarabiny - Google Patents

Estry fosfolipidowe klofarabiny

Info

Publication number
PL1606233T3
PL1606233T3 PL04721537T PL04721537T PL1606233T3 PL 1606233 T3 PL1606233 T3 PL 1606233T3 PL 04721537 T PL04721537 T PL 04721537T PL 04721537 T PL04721537 T PL 04721537T PL 1606233 T3 PL1606233 T3 PL 1606233T3
Authority
PL
Poland
Prior art keywords
clofarabin
phospholipid esters
phospholipid
esters
lipidesters
Prior art date
Application number
PL04721537T
Other languages
English (en)
Inventor
Dieter Herrmann
Birgit Heckl-Östreicher
Christian Lutz
Robert Voigt
William E Bauta
CHRISTOPH MüLLER
Original Assignee
Heidelberg Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heidelberg Pharma Gmbh filed Critical Heidelberg Pharma Gmbh
Publication of PL1606233T3 publication Critical patent/PL1606233T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fats And Perfumes (AREA)
PL04721537T 2003-03-19 2004-03-18 Estry fosfolipidowe klofarabiny PL1606233T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US45600303P 2003-03-19 2003-03-19
EP03006059A EP1460082A1 (en) 2003-03-19 2003-03-19 Phospholipid esters of clofarabine derivatives
PCT/EP2004/002810 WO2004083155A2 (en) 2003-03-19 2004-03-18 Nucleotide lipid ester derivatives
EP04721537A EP1606233B1 (en) 2003-03-19 2004-03-18 Phospholipid esters of Clofarabin

Publications (1)

Publication Number Publication Date
PL1606233T3 true PL1606233T3 (pl) 2006-10-31

Family

ID=33031244

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04721537T PL1606233T3 (pl) 2003-03-19 2004-03-18 Estry fosfolipidowe klofarabiny

Country Status (21)

Country Link
US (1) US7419965B2 (pl)
EP (2) EP1460082A1 (pl)
JP (1) JP2006520359A (pl)
KR (1) KR20050109939A (pl)
CN (1) CN100369926C (pl)
AT (1) ATE328000T1 (pl)
AU (1) AU2004222163A1 (pl)
CA (1) CA2519434A1 (pl)
CY (1) CY1105572T1 (pl)
DE (1) DE602004001047T2 (pl)
DK (1) DK1606233T3 (pl)
ES (1) ES2265636T3 (pl)
MX (1) MXPA05008817A (pl)
NO (1) NO20053903L (pl)
NZ (1) NZ542011A (pl)
PL (1) PL1606233T3 (pl)
PT (1) PT1606233E (pl)
RU (1) RU2347786C2 (pl)
SI (1) SI1606233T1 (pl)
WO (1) WO2004083155A2 (pl)
ZA (1) ZA200507541B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2070938A1 (en) * 2007-12-13 2009-06-17 Heidelberg Pharma AG Clofarabine dietherphospholipid derivatives
CN102079766A (zh) * 2009-11-29 2011-06-01 海南中化联合制药工业股份有限公司 一种单磷酸阿糖腺苷的制备方法
CN101709073B (zh) * 2009-12-01 2013-01-23 北京大学 核苷酸磷脂分子及脂质体及其制备方法和应用
CN103232510B (zh) * 2012-11-23 2015-12-23 北京大学 5’-氨基-2’,5’-双脱氧核苷酸磷脂分子及其制备方法和应用
US9771385B2 (en) * 2014-11-26 2017-09-26 Vascular Biogenics Ltd. Oxidized lipids
KR102371969B1 (ko) 2016-12-23 2022-03-08 주식회사 엘지에너지솔루션 배터리 모듈
JP7465416B2 (ja) * 2018-06-26 2024-04-11 ティーエスアールエル インコーポレイテッド 代謝安定性プロドラッグ
WO2024059754A1 (en) * 2022-09-14 2024-03-21 Quantapore, Inc. Polythiolated linkers for stable nanoparticle suspensions and uses thereof
AU2024370164A1 (en) * 2023-10-29 2026-05-14 Maia Biotechnology, Inc. Telomere-targeting phosphatidyl-thio conjugates

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
US4751221A (en) 1985-10-18 1988-06-14 Sloan-Kettering Institute For Cancer Research 2-fluoro-arabinofuranosyl purine nucleosides
JPS6383094A (ja) * 1986-09-27 1988-04-13 Toyo Jozo Co Ltd エ−テル型ヌクレオシド−リン脂質複合体
DE4026265A1 (de) 1990-08-20 1992-02-27 Boehringer Mannheim Gmbh Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel
US5512671A (en) * 1993-02-16 1996-04-30 Wake Forest University Ether lipid-nucleoside covalent conjugates
DE4321978A1 (de) * 1993-07-01 1995-01-12 Boehringer Mannheim Gmbh Liponucleotide von Desoxynucleosiden, deren Herstellung sowie deren Verwendung als antivirale Arzneimittel
AU711367B2 (en) * 1994-11-12 1999-10-14 Heidelberg Pharma Holding Gmbh Lipid-splitting enzyme
US7517858B1 (en) * 1995-06-07 2009-04-14 The Regents Of The University Of California Prodrugs of pharmaceuticals with improved bioavailability
US7026469B2 (en) * 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
US6670341B1 (en) * 1999-10-28 2003-12-30 Wake Forest University Health Sciences Compositions and methods for double-targeting virus infections and targeting cancer cells

Also Published As

Publication number Publication date
NO20053903L (no) 2005-12-19
EP1460082A1 (en) 2004-09-22
ATE328000T1 (de) 2006-06-15
EP1606233A2 (en) 2005-12-21
CA2519434A1 (en) 2004-09-30
PT1606233E (pt) 2006-09-29
WO2004083155A2 (en) 2004-09-30
NZ542011A (en) 2008-02-29
DE602004001047T2 (de) 2007-04-19
CN100369926C (zh) 2008-02-20
NO20053903D0 (no) 2005-08-22
RU2347786C2 (ru) 2009-02-27
EP1606233B1 (en) 2006-05-31
SI1606233T1 (sl) 2006-10-31
AU2004222163A1 (en) 2004-09-30
DE602004001047D1 (de) 2006-07-06
DK1606233T3 (da) 2006-09-18
WO2004083155A3 (en) 2005-03-31
RU2005130992A (ru) 2006-04-10
US7419965B2 (en) 2008-09-02
CY1105572T1 (el) 2010-07-28
KR20050109939A (ko) 2005-11-22
US20060293514A1 (en) 2006-12-28
ZA200507541B (en) 2006-05-31
CN1771253A (zh) 2006-05-10
MXPA05008817A (es) 2005-10-18
JP2006520359A (ja) 2006-09-07
ES2265636T3 (es) 2007-02-16

Similar Documents

Publication Publication Date Title
IL188249A0 (en) Cephalosporin related compounds for use in therapy
TW200612918A (en) Lonidamine analogs
ZA200409492B (en) Compositions and methods for the diagnosis and treatment of tumor.
AU2003237367A8 (en) Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer
WO2004030615A8 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1571968A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004016225A8 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004045516A9 (en) Compositions and methods for the diagnosis and treatment of tumor
IL165950A0 (en) Compositions and method for the diagnosis and treatment of tumor
EP1572091A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004060270A8 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2003057160A8 (en) Compositions and methods for the diagnosis and treatment of tumor
AU2003212634A8 (en) Compounds useful in the treatment of cancer
ZA200510282B (en) Compositions and methods for the diagnosis and treatment of tumor
AP2005003362A0 (en) Formulation and methods for the treatment of thrombocythemia.
AU2003237792A8 (en) Compositions and methods for the diagnosis and treatment of tumor
TW200510398A (en) Novel compounds
SI1606233T1 (sl) Fosfolipidni estri klofarabina
GB0207653D0 (en) Methods of using lamellar bodies for therapeutic purposes
ZA200604365B (en) Compositions and methods for the diagnosis and treatment of tumor
EP1684795A4 (en) METHODS AND AGENTS FOR THE TREATMENT OF CANCER
AU2003255504A8 (en) Use of 6 amino-quinoline-5, 8 quinones and nucleic acids associated with senescence for the treatment of tumors
MXPA05002477A (es) Asialo-interferones y el tratamiento de cancer de higado.
AU2003247094A8 (en) Enhancing the effect of radioimmunotherapy in the treatment of tumors
AU2002303430A8 (en) Compositions and methods for the diagnosis and treatment of tumor